Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjects

被引:32
|
作者
Hulot, J. -S. [1 ,2 ,3 ]
Wuerzner, G. [4 ]
Bachelot-Loza, C. [5 ]
Azizi, M. [4 ,6 ]
Blanchard, A. [4 ]
Peyrard, S. [4 ]
Funck-Brentano, C. [1 ,2 ,3 ]
Gaussem, P. [5 ,6 ,7 ]
机构
[1] Hop La Pitie Salpetriere, AP HP, Serv Pharmacol, Unite Pharmacogenet,Ctr Invest Biomed, F-75013 Paris, France
[2] Univ Paris, UPMC, Paris, France
[3] INSERM, UMR S 956, Paris, France
[4] Hop Europeen Georges Pompidou, AP HP, Ctr Invest Clin, INSERM,CIC 9201, Paris, France
[5] INSERM, UMR S 765, Fac Pharm, Paris, France
[6] Univ Paris 05, Paris, France
[7] Hop Europeen Georges Pompidou, AP HP, Serv Hematol Biol, Paris, France
关键词
OF-FUNCTION POLYMORPHISM;
D O I
10.1111/j.1538-7836.2009.03729.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:610 / 613
页数:4
相关论文
共 50 条
  • [1] Non-antiplatelet effect of clopidogrel: improving endothelial function in Chinese healthy subjects with different CYP2C19 genotype
    Zhang, Yin-Zhuang
    Chen, Bi-Lian
    Zhang, Wei
    Cao, Xin
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2015, 42 (01): : 22 - 26
  • [2] Non-antiplatelet effect of Clopidogrel: Improving endothelial function in Chinese healthy subjects with different CYP2C19 genotype
    Zhang, Yinzhuang
    Chen Bilian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C79 - C79
  • [3] The effect of CYP2C19 genotype on the platelet responsiveness to clopidogrel in healthy Korean subjects.
    Cho, D.
    Yeo, C.
    Oh, M.
    Shon, J.
    Kim, E.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S69 - S69
  • [4] Antiplatelet response to clopidogrel is associated with a haplotype in CYP2C19 gene in Pakistani patients
    Sagheer Ahmed
    Saima Gul
    Sami Siraj
    Abrar Hussain
    Fahad Sultan Sheikh
    Saeed Ullah Shah
    Kholood Janjua
    Hizbullah Khan
    Mohammad Hamid Hamdard
    Scientific Reports, 12
  • [5] IMPACT OF CYP2C19 GENOTYPING FOR IDENTIFICATION OF PATIENTS WITH ATTENUATED ANTIPLATELET RESPONSE TO CLOPIDOGREL
    Trenk, D.
    Hochholzer, W.
    Fromm, M. F.
    Zolk, O.
    Neumann, F. -J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 : 2 - 2
  • [6] Antiplatelet response to clopidogrel is associated with a haplotype in CYP2C19 gene in Pakistani patients
    Ahmed, Sagheer
    Gul, Saima
    Siraj, Sami
    Hussain, Abrar
    Sheikh, Fahad Sultan
    Shah, Saeed Ullah
    Janjua, Kholood
    Khan, Hizbullah
    Hamdard, Mohammad Hamid
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [7] Effect of CYP2C19 Polymorphisms on the Platelet Response to Clopidogrel and Influence on the Effect of High Versus Standard Dose Clopidogrel in Carotid Artery Stenting
    Gonzalez, A.
    Moniche, F.
    Cayuela, A.
    Garcia-Lozano, J. R.
    Torrecillas, F.
    Escudero-Martinez, I.
    Gonzalez-Marcos, J. R.
    Mayol, A.
    Montaner, J.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2016, 51 (02) : 175 - 186
  • [8] PHARMACOKINETICS AND RELATIVE BIOAVAILABILITY OF FIXED-DOSE COMBINATION OF CLOPIDOGREL AND ASPIRIN VERSUS CO-ADMINISTRATION OF INDIVIDUAL FORMULATIONS IN HEALTHY SUBJECTS
    Choi, H.
    Ghim, J.
    Oh, M.
    Shon, J.
    Park, S.
    Seo, J.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S37 - S37
  • [9] Different Influences of CYP2C19 Gene Polymorphisms on Antiplatelet Effect of Clopidogrel and Ticlopidine
    Asai, Toru
    Ishiguro, Hisaaki
    Umemoto, Norio
    Morishima, Mikio
    Harata, Syuji
    Shimizu, Kiyokazu
    Murohara, Toyoaki
    Maeda, Akimitsu
    Ando, Hitoshi
    Fujimura, Akio
    CIRCULATION, 2010, 122 (21)
  • [10] The impact of CYP2C19 gene polymorphism on the antiplatelet effect of clopidogrel and ticlopidine; the efficacy of ticlopidine on the non-responders of clopidogrel with CYP2C19 gene polymorphism
    Ishiguro, H.
    Asai, T.
    Umemoto, N.
    Sumida, A.
    Shimizu, K.
    Murohara, T.
    Maeda, A.
    Ando, H.
    Fujimura, A.
    EUROPEAN HEART JOURNAL, 2010, 31 : 968 - 968